| EMA number | EMEA/H/C/000588 |
| ATC code | A10AF01 |
| Authorisation | 24 January 2006 |
| Withdrawn | 26 September 2008 |
| Revision | 6 |
EXUBERA is indicated for the treatment of adult patients with type 2 diabetes mellitus notadequately controlled with oral antidiabetic agents and requiring insulin therapy.EXUBERA is also indicated for the treatment of adult patients with type 1 diabetes mellitus, inaddition to long or intermediate acting subcutaneous insulin, for whom the potential benefits ofadding inhaled insulin outweigh the potential safety concerns (see section 4.4).